John Markels
Vermögen: 21 012 $ am 31.05.2026
Vermögen: 21 012 $ am 31.05.2026
John H.
Markels is currently an Independent Director at Sangamo Therapeutics, Inc. since 2020.
Dr. Markels is also a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. Additionally, Dr. Markels serves as an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Dr. Markels earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of Delaware.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2025 | 96.384 ( 0,02 % ) | 21 012 $ | 31.05.2026 | |
| 05.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.02.2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 08.12.2022 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.03.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen